DevaCell Inc is a startup based in the United States.
DevaCell Inc develops synthetic vector-based immunotherapies, including oncolytic virus therapies, vaccines, and gene therapies, designed to selectively attack tumor cells and enhance the patient immune system.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.